These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6684409)

  • 1. [Hypertrophic obstructive cardiomyopathy and atrial fibrillation. 9 cases].
    Ollivier JP; Pleskof A; Duret JC; Coignard A; Berger P; Droniou J
    Ann Med Interne (Paris); 1983; 134(4):310-3. PubMed ID: 6684409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertrophic cardiomyopathy in the elderly: significance of atrial fibrillation.
    Doi Y; Kitaoka H
    J Cardiol; 2001; 37 Suppl 1():133-8. PubMed ID: 11433817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substrate and procedural predictors of outcomes after catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Bunch TJ; Munger TM; Friedman PA; Asirvatham SJ; Brady PA; Cha YM; Rea RF; Shen WK; Powell BD; Ommen SR; Monahan KH; Haroldson JM; Packer DL
    J Cardiovasc Electrophysiol; 2008 Oct; 19(10):1009-14. PubMed ID: 18479329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Paroxysmal atrial fibrillation: main cause of syncope in hypertrophic cardiomyopathy].
    Brembilla-Perrot B; Terrier de La Chaise A; Beurrier D
    Arch Mal Coeur Vaiss; 1993 Nov; 86(11):1573-8. PubMed ID: 8010857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective investigation of hospitalized patients with atrial fibrillation in mainland China.
    Society of Cardiology, Chinese Medical Association
    Chin Med J (Engl); 2004 Dec; 117(12):1763-7. PubMed ID: 15603701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P-wave durations as a predictor for atrial fibrillation development in patients with hypertrophic cardiomyopathy.
    Ozdemir O; Soylu M; Demir AD; Topaloglu S; Alyan O; Turhan H; Bicer A; Kutuk E
    Int J Cardiol; 2004 Apr; 94(2-3):163-6. PubMed ID: 15093974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of atrial fibrillation surgery in patients with hypertrophic cardiomyopathy.
    Chen MS; McCarthy PM; Lever HM; Smedira NG; Lytle BL
    Am J Cardiol; 2004 Feb; 93(3):373-5. PubMed ID: 14759397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Idiopathic atrial fibrillation: clinical-instrumental characterization and thromboembolic risk].
    Boriani G; Capucci A; Bruni V; Spedicato L; Biffi M; Sabbatani P; Frabetti L; Branzi A; Magnani B
    Cardiologia; 1995 Jan; 40(1):23-30. PubMed ID: 8529235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined cox maze procedure, septal myectomy, and mitral valve replacement for severe hypertrophic obstructive cardiomyopathy complicated by chronic atrial fibrillation.
    Matsui Y; Fukada Y; Imai T; Naito Y; Sasaki S
    Ann Thorac Cardiovasc Surg; 2003 Oct; 9(5):323-5. PubMed ID: 14672530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mitral annular calcifications in patients with hypertrophic obstructive cardiomyopathy: an echocardiographic study].
    Tominaga S; Honda M; Yanagisawa N; Noike H; Nakajima H; Yamaguchi Y; Watanabe T; Higuchi Y; Wada T; Matsuyama S
    J Cardiogr; 1982 Dec; 12(4):875-84. PubMed ID: 6892248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ventricular fibrillation induced by rapid atrial rates in patients with hypertrophic cardiomyopathy.
    López Gil M; Arribas F; Cosío FG
    Europace; 2000 Oct; 2(4):327-32. PubMed ID: 11194600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy.
    Lin G; Nishimura RA; Gersh BJ; Phil D; Ommen SR; Ackerman MJ; Brady PA
    Heart; 2009 May; 95(9):709-14. PubMed ID: 19282314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation between angiotensin-converting enzyme II genotype and atrial fibrillation in Japanese patients with hypertrophic cardiomyopathy.
    Ogimoto A; Hamada M; Nakura J; Miki T; Hiwada K
    J Hum Genet; 2002; 47(4):184-9. PubMed ID: 12166654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive risk stratification prevents sudden death due to paroxysmal atrial fibrillation in hypertrophic cardiomyopathy.
    Limongelli G; Elliott PM; Pacileo G; Sarubbi B; Thaman R; Calabrò P; Vergara P; Iacomino M; Russo MG; Calabrò R
    J Cardiovasc Med (Hagerstown); 2006 Sep; 7(9):711-3. PubMed ID: 16932087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial fibrillation in hypertrophic cardiomyopathy: mechanisms, embolic risk and prognosis.
    Nair AG; Fischer AG
    Anadolu Kardiyol Derg; 2006 Dec; 6 Suppl 2():40-3. PubMed ID: 17162269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: results from the Canadian Registry of Atrial Fibrillation.
    Kerr CR; Humphries KH; Talajic M; Klein GJ; Connolly SJ; Green M; Boone J; Sheldon R; Dorian P; Newman D
    Am Heart J; 2005 Mar; 149(3):489-96. PubMed ID: 15864238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of percutaneous transluminal septal myocardial ablation on refractory paroxysmal atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy.
    Hosokawa Y; Takano H; Ohno T; Takayama M; Takano T
    Angiology; 2008; 59(3):329-34. PubMed ID: 18388103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common atrial flutter and atrial fibrillation are not always two stages of the same disease. A long-term follow-up study in patients with atrial flutter treated with cavo-tricuspid isthmus ablation.
    Delise P; Sitta N; Corò L; Marras E; Sciarra L; Bocchino M; Berton G
    J Cardiovasc Med (Hagerstown); 2006 Nov; 7(11):800-5. PubMed ID: 17060805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Supraventricular tachycardia in obstructive myocardiopathy. A retrospective study of 51 cases by the Working Group on myocardiography].
    Bouhour JB; Bory M; Bourmayan C; Chiffoleau S; Favereau X; Foussard C; Komajda M; Lassabe G; Morand P; Neimann JL
    Arch Mal Coeur Vaiss; 1981 Sep; 74(9):993-1000. PubMed ID: 6794523
    [No Abstract]   [Full Text] [Related]  

  • 20. [Obstructive hypertrophic cardiomyopathy: medical or surgical treatment?].
    Azzano O; Garé JP; de Gevigney G; Milon H; Mikaeloff P; Delahaye JP
    Arch Mal Coeur Vaiss; 1993 Jul; 86(7):987-93. PubMed ID: 8291946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.